108 related articles for article (PubMed ID: 1404649)
21. Fine needle aspiration of metastatic malignant Leydig cell tumor of testis: a case report.
Naik R; Upadhyaya K; Pai MR; Baliga PB; Nayak SK
Indian J Pathol Microbiol; 2007 Jul; 50(3):624-5. PubMed ID: 17883165
[TBL] [Abstract][Full Text] [Related]
22. The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring.
van Slooten H; Moolenaar AJ; van Seters AP; Smeenk D
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):47-53. PubMed ID: 6537915
[TBL] [Abstract][Full Text] [Related]
23. Clinical role of determination of plasma mitotane and its metabolites levels in patients with adrenal cancer: results of a long-term follow-up.
Kasperlik-Zaluska AA; Cichocki A
J Exp Ther Oncol; 2005; 5(2):125-32. PubMed ID: 16471038
[TBL] [Abstract][Full Text] [Related]
24. Metastatic Leydig cell tumor of the testis. Report of three cases and review of the literature.
Grem JL; Robins HI; Wilson KS; Gilchrist K; Trump DL
Cancer; 1986 Nov; 58(9):2116-9. PubMed ID: 3756826
[TBL] [Abstract][Full Text] [Related]
25. Mitotane effects in a H295R xenograft model of adjuvant treatment of adrenocortical cancer.
Lindhe O; Skogseid B
Horm Metab Res; 2010 Sep; 42(10):725-30. PubMed ID: 20665429
[TBL] [Abstract][Full Text] [Related]
26. [Metabolism of o,p'-DDD (mitotane) in human and animals. Actual notions and practical deductions (author's transl)].
Touitou Y; Bogdan A; Legrand JC; Desgrez P
Ann Endocrinol (Paris); 1977; 38(1):13-25. PubMed ID: 324349
[TBL] [Abstract][Full Text] [Related]
27. [Testicular malignant Leydig cell tumor: A case report].
Lu W; Zhang M; Wang SP; Wang X; Cai ZM
Zhonghua Nan Ke Xue; 2016 May; 22(5):442-5. PubMed ID: 27416670
[TBL] [Abstract][Full Text] [Related]
28. The effect of o,p'-DDD on adrenal steroid replacement therapy requirements.
Robinson BG; Hales IB; Henniker AJ; Ho K; Luttrell BM; Smee IR; Stiel JN
Clin Endocrinol (Oxf); 1987 Oct; 27(4):437-44. PubMed ID: 2830062
[TBL] [Abstract][Full Text] [Related]
29. Adrenocortical carcinoma responded to treatment with o,p'-DDD--a case report.
Naruse T; Koike A; Kato K; Ishii T; Suzumura K; Matsumoto K
Endocrinol Jpn; 1984 Aug; 31(4):417-26. PubMed ID: 6097439
[TBL] [Abstract][Full Text] [Related]
30. Comparative CYP-dependent binding of the adrenocortical toxicants 3-methylsulfonyl-DDE and o,p'-DDD in Y-1 adrenal cells.
Hermansson V; Asp V; Bergman A; Bergström U; Brandt I
Arch Toxicol; 2007 Nov; 81(11):793-801. PubMed ID: 17487473
[TBL] [Abstract][Full Text] [Related]
31. A case of recurrent adrenocortical carcinoma, with observations on long-term o,p'-DDD therapy and complications.
van Aalderen W; van Seters AP; Backer ET; Chang PC; van Krieken JH; Moolenaar AJ
Neth J Med; 1992 Oct; 41(3-4):161-70. PubMed ID: 1470288
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of 1-(0-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (o,p'-DDD) in rats.
Reif VD; Sinsheimer JE
Drug Metab Dispos; 1975; 3(1):15-25. PubMed ID: 234830
[TBL] [Abstract][Full Text] [Related]
33. [Late metastasis of an extragonadal Leydig cell tumor].
Kleinhans G; Cohausz G; Dorst KG; Witting C; Neuber A
Urologe A; 1989 Jul; 28(4):231-3. PubMed ID: 2763398
[TBL] [Abstract][Full Text] [Related]
34. [The long-term therapy of hypothalamic-hypophyseal Cushing's syndrome with mitotane (o,p'-DDD)].
Knappe G; Gerl H; Ventz M; Rohde W
Dtsch Med Wochenschr; 1997 Jul; 122(28-29):882-6. PubMed ID: 9264918
[TBL] [Abstract][Full Text] [Related]
35. Metastatic Leydig cell tumor with sarcomatoid differentiation.
Gulbahce HE; Lindeland AT; Engel W; Lillemoe TJ
Arch Pathol Lab Med; 1999 Nov; 123(11):1104-7. PubMed ID: 10539917
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p'-DDD (mitotane) in Minipigs.
Hermansson V; Cantillana T; Hovander L; Bergman A; Ljungvall K; Magnusson U; Törneke K; Brandt I
Cancer Chemother Pharmacol; 2008 Feb; 61(2):267-74. PubMed ID: 17431626
[TBL] [Abstract][Full Text] [Related]
37. Chiral effects in adrenocorticolytic action of o,p'-DDD (mitotane) in human adrenal cells.
Asp V; Cantillana T; Bergman A; Brandt I
Xenobiotica; 2010 Mar; 40(3):177-83. PubMed ID: 20044879
[TBL] [Abstract][Full Text] [Related]
38. Estimation of o,p'-DDD in plasma by gas-liquid chromatography.
Moolenaar AJ; Niewint JW; Oei IT
Clin Chim Acta; 1977 Apr; 76(2):213-8. PubMed ID: 862195
[TBL] [Abstract][Full Text] [Related]
39. Extremely long survival in six patients despite recurrent and metastatic adrenal carcinoma.
Hermsen IG; Gelderblom H; Kievit J; Romijn JA; Haak HR
Eur J Endocrinol; 2008 Jun; 158(6):911-9. PubMed ID: 18505909
[TBL] [Abstract][Full Text] [Related]
40. Malignant Leydig cell tumour of the testis.
Powari M; Kakkar N; Singh SK; Rai RS; Jogai S
Urol Int; 2002; 68(1):63-5. PubMed ID: 11803271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
